{"transactions":[{"id":2265213,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-18T23:19:17.000Z","date":"2022-05-16","kind":"tax_withholding","acquired":false,"shares":832,"price":5.67,"value":4717.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":121110,"source":{"system":"sec-edgar","filing":"0001209191-22-030255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122030255/doc4.xml","form_type":"4"}},{"id":2307161,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T20:06:42.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":9072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."}],"balance_after":669356,"derivative":{"exercise_price":2.48,"expiration_date":"2030-12-30","underlying":"Class A Common Stock","underlying_shares":669356},"source":{"system":"sec-edgar","filing":"0001209191-22-022310","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122022310/doc4.xml","form_type":"4"}},{"id":2307160,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-04-04T20:06:42.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":9072,"price":2.48,"value":22498.56,"ownership":{"direct":true},"balance_after":121942,"source":{"system":"sec-edgar","filing":"0001209191-22-022310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122022310/doc4.xml","form_type":"4"}},{"id":2364344,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T01:00:24.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."}],"balance_after":678428,"derivative":{"exercise_price":2.48,"expiration_date":"2030-12-30","underlying":"Class A Common Stock","underlying_shares":678428},"source":{"system":"sec-edgar","filing":"0001209191-22-014405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122014405/doc4.xml","form_type":"4"}},{"id":2364343,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-02T01:00:24.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":15625,"price":2.48,"value":38750.0,"ownership":{"direct":true},"balance_after":112870,"source":{"system":"sec-edgar","filing":"0001209191-22-014405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122014405/doc4.xml","form_type":"4"}},{"id":2407877,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-09T02:09:45.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":4784,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4784,"derivative":{"exercise_price":11.4,"exercise_date":"2022-02-04","expiration_date":"2032-02-04","underlying":"Class A Common Stock","underlying_shares":4784},"source":{"system":"sec-edgar","filing":"0001209191-22-007915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007915/doc4.xml","form_type":"4"}},{"id":2407876,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-09T02:09:45.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":76998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":76998,"derivative":{"exercise_price":11.4,"expiration_date":"2032-02-04","underlying":"Class A Common Stock","underlying_shares":76998},"source":{"system":"sec-edgar","filing":"0001209191-22-007915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007915/doc4.xml","form_type":"4"}},{"id":2407875,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-09T02:09:45.000Z","date":"2022-02-04","kind":"tax_withholding","acquired":false,"shares":981,"price":11.4,"value":11183.4,"ownership":{"direct":true},"balance_after":97245,"source":{"system":"sec-edgar","filing":"0001209191-22-007915","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007915/doc4.xml","form_type":"4"}},{"id":2407874,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-09T02:09:45.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":2392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":98226,"source":{"system":"sec-edgar","filing":"0001209191-22-007915","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007915/doc4.xml","form_type":"4"}},{"id":2407873,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-09T02:09:45.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":38499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter."}],"balance_after":95834,"source":{"system":"sec-edgar","filing":"0001209191-22-007915","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122007915/doc4.xml","form_type":"4"}},{"id":2415813,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T01:11:45.000Z","date":"2022-01-31","kind":"exercise","acquired":false,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."}],"balance_after":694053,"derivative":{"exercise_price":2.48,"expiration_date":"2030-12-30","underlying":"Class A Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001209191-22-006598","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122006598/doc4.xml","form_type":"4"}},{"id":2415812,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-03T01:11:45.000Z","date":"2022-01-31","kind":"exercise","acquired":true,"shares":15625,"price":2.48,"value":38750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,388 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021"}],"balance_after":57335,"source":{"system":"sec-edgar","filing":"0001209191-22-006598","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122006598/doc4.xml","form_type":"4"}},{"id":2442788,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T01:48:32.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":40322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."}],"balance_after":709678,"derivative":{"exercise_price":2.47,"expiration_date":"2030-12-30","underlying":"Class A Common Stock","underlying_shares":40322},"source":{"system":"sec-edgar","filing":"0001209191-22-002062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122002062/doc4.xml","form_type":"4"}},{"id":2442787,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-06T01:48:32.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":40322,"price":2.47,"value":99595.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person."}],"balance_after":40322,"source":{"system":"sec-edgar","filing":"0001209191-22-002062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122002062/doc4.xml","form_type":"4"}},{"id":2741567,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:53:40.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-Five percent (25%) of the shares subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO."}],"balance_after":750000,"derivative":{"exercise_price":2.47,"expiration_date":"2030-12-30","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001209191-21-028028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028028/doc4.xml","form_type":"4"}},{"id":2741566,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":127180,"kind":"person","name":"Doyle Ramona","position":1,"cik":"0001856069","reported_name":"Doyle Ramona","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:53:40.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-Five percent (25%) of the shares subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO."}],"balance_after":0,"derivative":{"exercise_price":2.47,"expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001209191-21-028028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028028/doc4.xml","form_type":"4"}}]}